Vaginal Hormone Therapy vs Oral HRT: What's the Difference

When a doctor discusses hormone therapy for menopause, one of the first decisions is whether a vaginal (local) option or an oral or transdermal (systemic) option is the better fit. Both use similar hormone classes, including conjugated oestrogens, but they're absorbed differently and are aimed at different symptoms. Understanding this distinction can make the conversation with your doctor more straightforward.

What "Local" and "Systemic" Mean

Systemic hormone therapy, whether as a tablet, patch, gel, or spray, is designed to raise hormone levels throughout the bloodstream. This means it can influence symptoms occurring anywhere in the body, such as hot flushes, night sweats, and mood changes, and it's also linked to some bone protection benefits.

Local, or vaginal, hormone therapy is applied directly to the vaginal tissue, most often as a cream such as Premarin Vaginal Cream. Because it's absorbed mainly by the tissue it's applied to, with comparatively little reaching the rest of the bloodstream, its effects are concentrated on vaginal and, to some extent, lower urinary tract symptoms.

What Each Option Is Typically Used For

Systemic Therapy

Doctors generally reach for systemic HRT when a woman's main complaints are whole-body symptoms like hot flushes, sleep disruption linked to night sweats, or mood symptoms tied to the menopause transition. It may also be considered as part of a broader conversation about bone health in some women.

Vaginal Therapy

Vaginal therapy is the more targeted option for symptoms confined to the vaginal and vulval area, such as dryness, discomfort during intercourse, irritation, or some urinary symptoms. Because less hormone reaches general circulation, it's sometimes considered even for women who aren't suitable candidates for systemic HRT, though this is always an individual decision made with a doctor.

Can They Be Used Together?

Some women are prescribed both systemic and vaginal therapy if they have both whole-body symptoms and localised vaginal symptoms that haven't fully resolved on systemic treatment alone. This isn't unusual and reflects the fact that systemic oestrogen doesn't always fully address local tissue symptoms for every woman. Whether combination therapy is appropriate depends entirely on individual circumstances, so it's a conversation for your doctor, not something to decide alone.

Why the Distinction Matters

Choosing between local and systemic therapy, or discussing whether both are appropriate, isn't just a formulation preference. It affects what symptoms are likely to improve, how much hormone reaches the wider body, and what monitoring or precautions your doctor may recommend. Women with certain medical histories may be steered toward one option over the other for safety reasons specific to their situation.

You can explore the range of formulations available in the Women's Health category, but the right choice always comes down to a discussion with your GP or specialist about your specific symptoms and medical history.

As with any hormone therapy, read the patient information leaflet for whichever product is prescribed, and raise any questions about how it works, what to expect, or how it might interact with other medicines with your doctor or pharmacist.